http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102020699-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a42d396369b77b87cf885141edea56c
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-097
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
filingDate 2009-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e6d18c1cde0503b5466d00305fc7119
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f72e4b928d18d503a01af8534f76c417
publicationDate 2013-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102020699-B
titleOfInvention Anti-platelet aggregation peptide and application thereof
abstract The invention provides an anti-platelet aggregation optically active polypeptide compound. The compound consists of three amino acids, namely levorotatory or dextrorotatory tryptophan, asparagine and pyroglutamic acid, and is used for treating platelet aggregation-related heart cerebrovascular diseases, such as ischemic stroke, inflammation, asthma and the like.
priorityDate 2009-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421109490
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9060
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426150211
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6267
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID83887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7405
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531296
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517573
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486105
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6327611
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546934
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527521
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449847384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419548926
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453134186
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558042
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10236
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487551
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414804309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421335186
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555909
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9849766
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9855476
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6456

Total number of triples: 46.